168.00
-8.00
(-4.55%)
As of 11:07:52 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,380,700
3,380,700
3,395,700
4,174,700
3,449,200
Cost of Revenue
1,856,300
1,856,300
1,828,100
1,996,600
1,610,300
Gross Profit
1,524,400
1,524,400
1,567,600
2,178,100
1,838,900
Operating Expense
1,087,200
1,087,200
1,023,700
1,038,800
905,500
Operating Income
437,200
437,200
543,900
1,139,300
933,400
Net Non Operating Interest Income Expense
-183,300
-183,300
-153,600
-24,900
-22,800
Pretax Income
186,800
186,800
386,700
1,181,700
668,400
Tax Provision
49,400
49,400
96,100
268,600
241,400
Net Income Common Stockholders
84,000
84,000
205,600
678,100
318,900
Diluted NI Available to Com Stockholders
84,000
84,000
205,600
678,100
318,900
Basic EPS
1.21
--
3.00
9.91
4.66
Diluted EPS
1.21
--
3.00
9.91
4.66
Basic Average Shares
34,230.55
--
34,226.01
34,226.01
34,226.01
Diluted Average Shares
34,230.55
--
34,226.01
34,226.01
34,226.01
Total Expenses
2,943,500
2,943,500
2,851,800
3,035,400
2,515,800
Net Income from Continuing & Discontinued Operation
84,000
84,000
205,600
678,100
318,900
Normalized Income
128,233.60
128,233.60
183,040
586,886
480,439.20
Interest Income
22,100
22,100
4,600
1,000
400
Interest Expense
184,100
184,100
144,900
35,200
27,000
Net Interest Income
-183,300
-183,300
-153,600
-24,900
-22,800
EBIT
370,900
370,900
531,600
1,216,900
695,400
EBITDA
786,800
786,800
873,200
1,504,000
926,600
Reconciled Cost of Revenue
1,856,300
1,856,300
1,828,100
1,996,600
1,610,300
Reconciled Depreciation
415,900
415,900
341,600
287,100
231,200
Net Income from Continuing Operation Net Minority Interest
84,000
84,000
205,600
678,100
318,900
Total Unusual Items Excluding Goodwill
-60,100
-60,100
30,000
118,000
-252,800
Total Unusual Items
-60,100
-60,100
30,000
118,000
-252,800
Normalized EBITDA
846,900
846,900
843,200
1,386,000
1,179,400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-15,866.40
-15,866.40
7,440
26,786
-91,260.80
12/31/2021 - 4/6/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FIE.DE Fielmann Group AG
43.40
-0.23%
CBHD.DE Coloplast A/S
95.02
+0.17%
DIM.PA Sartorius Stedim Biotech S.A.
183.50
-4.10%
BIG1.DE Bio-Gate AG
0.8400
0.00%
BOX.DE Becton, Dickinson and Company
178.70
-0.67%
IUI1.DE Intuitive Surgical, Inc.
432.60
0.00%
ESL.DE EssilorLuxottica Société anonyme
248.00
-2.17%
56S1.DE Sartorius Stedim Biotech S.A.
172.75
0.00%
SKAN.SW SKAN Group AG
62.00
-0.48%
FIE.BE Fielmann AG
43.50
+0.46%